...
首页> 外文期刊>EFSA Journal >Scientific Opinion on application (EFSA‐GMO‐DE‐2011‐95) for the placing on the market of genetically modified maize 5307 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Syngenta Crop Protection AG
【24h】

Scientific Opinion on application (EFSA‐GMO‐DE‐2011‐95) for the placing on the market of genetically modified maize 5307 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Syngenta Crop Protection AG

机译:根据先正达作物保护公司(EC)第1829/2003号条例(EC)第1829/2003号规定,将用于食品和饲料用途,进口和加工的转基因玉米5307投放市场的申请的科学意见(EFSA-GMO-DE-2011-95)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Maize 5307 was developed by Agrobacterium tumefaciens‐mediated transformation to express two proteins: eCry3.1Ab, conferring resistance to certain coleopteran pests, and phosphomannose isomerase (PMI), used as selection marker. The molecular characterisation showed relevant similarities between the amino acid sequence of PMI and a known allergen, and between the amino acid sequence of eCry3.1Ab and a potential toxin. Some agronomic and phenotypic differences between maize 5307 and its conventional counterpart were observed (higher ‘heat units to 50 % pollen shed’, grain moisture, plant height, grain yield); however, the EFSA GMO Panel considered that these do not give rise to food/feed or environmental safety concerns. No differences in the compositional data requiring further safety assessment were identified. There were no concerns regarding the potential toxicity and allergenicity of the PMI protein. The EFSA GMO Panel could not conclude on the safety of the eCry3.1Ab protein due to the inadequate 28‐day toxicity study provided. The outcome of a broiler feeding study with maize 5307 was not assessed by the EFSA GMO Panel, due to study weaknesses. There are no indications of an increased likelihood of the establishment and spread of feral maize plants. Interactions with the biotic and abiotic environment were not considered to be a relevant issue. Risks associated with the unlikely but theoretically possible horizontal gene transfer of recombinant genes from maize 5307 to bacteria were not identified. The post‐market environmental monitoring plan and reporting intervals are in line with the scope of the application. In conclusion, in the absence of an appropriate assessment of eCry3.1Ab, the EFSA GMO Panel is not in a position to complete its food/feed risk assessment of maize 5307. However, the EFSA GMO Panel concludes that the maize 5307 is unlikely to have any adverse effect on the environment in the context of its scope.
机译:玉米5307是通过根癌农杆菌介导的转化而开发的,可表达两种蛋白质:eCry3.1Ab(赋予对某些鞘翅目害虫的抗性)和磷酸甘露糖异构酶(PMI)用作选择标记。分子表征显示PMI的氨基酸序列与已知的过敏原之间以及eCry3.1Ab的氨基酸序列与潜在毒素之间存在相似的相似性。观察到玉米5307与常规玉米之间在农艺和表型上存在差异(“到50%花粉脱落的热量单位”较高,谷物水分,株高,谷物产量);但是,欧洲食品安全局(EFSA)GMO小组认为,这些不会引起食品/饲料或环境安全问题。没有发现需要进一步安全评估的成分数据之间的差异。无需担心PMI蛋白的潜在毒性和致敏性。由于提供的28天毒性研究不足,EFSA GMO专家组无法就eCry3.1Ab蛋白的安全性得出结论。由于研究薄弱,EFSA GMO小组未评估用玉米5307喂养肉鸡的研究结果。没有迹象表明野生玉米植株的建立和传播的可能性增加。与生物和非生物环境的相互作用不被视为相关问题。尚未确定与重组基因从玉米5307到细菌的不可能但理论上可能的水平基因转移相关的风险。上市后环境监测计划和报告间隔与申请范围相符。总之,在没有对eCry3.1Ab进行适当评估的情况下,EFSA GMO小组无法完成对玉米5307的食物/饲料风险评估。但是,EFSA GMO小组认为玉米5307不太可能对玉米进行评估。在其范围内对环境有任何不利影响。

著录项

  • 来源
    《EFSA Journal》 |2015年第5期|共29页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号